JPWO2023132333A5 - - Google Patents

Info

Publication number
JPWO2023132333A5
JPWO2023132333A5 JP2023572475A JP2023572475A JPWO2023132333A5 JP WO2023132333 A5 JPWO2023132333 A5 JP WO2023132333A5 JP 2023572475 A JP2023572475 A JP 2023572475A JP 2023572475 A JP2023572475 A JP 2023572475A JP WO2023132333 A5 JPWO2023132333 A5 JP WO2023132333A5
Authority
JP
Japan
Prior art keywords
cancer
cdr
amino acid
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572475A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023132333A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/000019 external-priority patent/WO2023132333A1/ja
Publication of JPWO2023132333A1 publication Critical patent/JPWO2023132333A1/ja
Publication of JPWO2023132333A5 publication Critical patent/JPWO2023132333A5/ja
Pending legal-status Critical Current

Links

JP2023572475A 2022-01-04 2023-01-04 Pending JPWO2023132333A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022000160 2022-01-04
PCT/JP2023/000019 WO2023132333A1 (ja) 2022-01-04 2023-01-04 がんを処置するための医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023132333A1 JPWO2023132333A1 (https=) 2023-07-13
JPWO2023132333A5 true JPWO2023132333A5 (https=) 2026-01-15

Family

ID=87073669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572475A Pending JPWO2023132333A1 (https=) 2022-01-04 2023-01-04

Country Status (5)

Country Link
US (1) US20250136679A1 (https=)
EP (1) EP4461313A4 (https=)
JP (1) JPWO2023132333A1 (https=)
CN (1) CN118510542A (https=)
WO (1) WO2023132333A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4346540B2 (ja) * 2003-11-10 2009-10-21 浩 藤原 絨毛外栄養膜細胞特異的蛋白質
JP2019158613A (ja) * 2018-03-13 2019-09-19 国立大学法人金沢大学 laeverinを用いたPSTT(胎盤部トロホブラスト腫瘍)の検出

Similar Documents

Publication Publication Date Title
CN102971343B (zh) 用于癌症诊断和/或预后的新型抗体
JP2015533788A5 (https=)
CN112703012A (zh) 治疗癌症的方法
JP6138780B2 (ja) 癌の検出および診断のための抗体i−3859の使用
JP2014529297A (ja) 新規な抗cxcr4抗体並びに癌の検出および診断のためのその使用
JP6815331B2 (ja) 前立腺がんの分析のための組成物及び方法
WO2017053250A1 (en) Antibody that binds to human programmed death ligand 2 (pd-l2) and uses thereof
Even-Desrumeaux et al. Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches
US20230176060A1 (en) Tumour biomarkers for immunotherapy
CN107850596A (zh) 用于检测组织浸润nk细胞的方法
CN111735946A (zh) 血清aldh1b1自身抗体定量检测试剂盒及其应用
KR102111699B1 (ko) 메티오닐-티알엔에이 합성효소를 이용한 췌장암 진단 방법 및 이를 이용한 췌장암 진단 키트
JP6977105B2 (ja) Igf−1r抗体および癌の診断のためのその使用
JPWO2023132333A5 (https=)
JP2023527771A (ja) 抗ヒトlag-3抗体および免疫組織化学(ihc)でのその使用
CN118791613A (zh) 抗msln纳米抗体及其制备方法与用途
JP7086607B2 (ja) Igf-1r抗体および癌の診断のためのその使用
JP2024513880A (ja) 免疫組織化学法およびkir3dl2特異的薬剤
CN118978593B (zh) 人半乳糖凝集素-3蛋白水平的测定方法及应用
Li et al. Selection of potential cytokeratin-18 monoclonal antibodies following IGH repertoire evaluation in mice
WO2018213680A1 (en) Diagnostic antibodies and methods of use
CN118255886A (zh) 抗msln纳米抗体及其制备方法与用途
WO2017201440A1 (en) Anti-ascl1 antibodies and methods of use
CN119855833A (zh) 用于在免疫组织化学(ihc)方案中使用和用于诊断癌症的抗人icos抗体
CN121595870A (zh) 一种用于检测血清ptgs1蛋白的双抗体夹心elisa试剂盒